ASHLEY TAYLOR: Open Payments
NPI 1447654306 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 12 payments from 7 companies in 2025. Trend: 2023 $72 · 2024 $181 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $145 |
| IMMUNITYBIO, INC. | 2 | $39 |
| Antares Pharma, Inc. | 2 | $34 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| UROGEN PHARMA, INC. | 1 | $16 |
Products named: RYBREVANT, ANKTIVA, ERLEADA, XYOSTED, Bard InLay Optima Ureteral Stent with HydroGlide Guidewire, GEMTESA, LYNPARZA, ZUSDURI.
Industry payments across SD — which companies pay providers there.
